<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02098226</url>
  </required_header>
  <id_info>
    <org_study_id>BDAL-2013-001</org_study_id>
    <nct_id>NCT02098226</nct_id>
  </id_info>
  <brief_title>Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts</brief_title>
  <official_title>Method Comparison Protocol: MALDI Biotyper-Clinical Applications (MBT-CA) Phase 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bruker Daltonics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bruker Daltonics</source>
  <brief_summary>
    <textblock>
      The study objective is to confirm that the MBT-CA System identifies medically significant&#xD;
      bacteria and yeasts from an isolated colony from any sample type processed by the clinical&#xD;
      laboratory. For this purpose MBT-CA test results will be compared to bi-directional&#xD;
      sequencing results.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bacteria or yeast isolates (1) fresh from primary culture plates, (2) collected directly from&#xD;
      clinical samples, stored in the refrigerator or frozen or (3) well characterized organisms&#xD;
      from a variety of contemporary culture collections will be included in the study. All&#xD;
      organisms to be included in the study will be cultured on an agar medium prior to&#xD;
      measurement.&#xD;
&#xD;
      Testing will be performed for various Gram negative and Gram positive bacteria and yeasts as&#xD;
      outlined below. Several thousands of samples will be measured via MBT-CA systems based on&#xD;
      MALDI-TOF MS technology (matrix assisted laser desorption ionisation time-of-flight mass&#xD;
      spectrometry) at the test sites as fresh or frozen isolates of bacteria and yeasts. Lower&#xD;
      prevalence organisms may be supplemented from banked culture collections.&#xD;
&#xD;
      The MBT-CA system uses an organism identification based on unique protein patterns of the&#xD;
      microorganisms obtained from mass spectrometry. The test organism's spectrum (a pattern of&#xD;
      mass peaks) is compared with a reference spectra library (database). Using biostatistical&#xD;
      analysis, a probability ranking of the organism identification is generated. The probability&#xD;
      ranking is represented as a log(score) between 0.00 and 3.00. Organism identification is&#xD;
      reported with high confidence if the log(score) is â‰¥ 2.00. An organism identification is&#xD;
      reported with low confidence if the log(score) is between 1.70 and &lt;2.00.&#xD;
&#xD;
      In the last step the samples are sent to a special site for sequencing. Finally, the&#xD;
      respective sequencing results are compared with the MBT-CA results.&#xD;
&#xD;
      Target microorganisms of study:&#xD;
&#xD;
        1. Acinetobacter haemolyticus&#xD;
&#xD;
        2. Acinetobacter johnsonii&#xD;
&#xD;
        3. Acinetobacter junii&#xD;
&#xD;
        4. Actinomyces meyeri&#xD;
&#xD;
        5. Actinomyces neuii&#xD;
&#xD;
        6. Actinomyces odontolyticus&#xD;
&#xD;
        7. Actinomyces oris&#xD;
&#xD;
        8. Aerococcus urinae&#xD;
&#xD;
        9. Aerococcus viridans&#xD;
&#xD;
       10. Aeromonas salmonicida&#xD;
&#xD;
       11. Anaerococcus vaginalis&#xD;
&#xD;
       12. Bacteroides fragilis&#xD;
&#xD;
       13. Bacteroides uniformis&#xD;
&#xD;
       14. Bacteroides_ovatus group&#xD;
&#xD;
       15. Bacteroides_thetaiotaomicron group&#xD;
&#xD;
       16. Bacteroides_vulgatus group&#xD;
&#xD;
       17. Bordetella group[3]&#xD;
&#xD;
       18. Bordetella hinzii&#xD;
&#xD;
       19. Brevibacterium casei&#xD;
&#xD;
       20. Brevundimonas_diminuta group&#xD;
&#xD;
       21. Campylobacter coli&#xD;
&#xD;
       22. Campylobacter jejuni&#xD;
&#xD;
       23. Campylobacter ureolyticus&#xD;
&#xD;
       24. Candida albicans&#xD;
&#xD;
       25. Candida boidinii&#xD;
&#xD;
       26. Candida dubliniensis&#xD;
&#xD;
       27. Candida duobushaemulonii&#xD;
&#xD;
       28. Candida famata&#xD;
&#xD;
       29. Candida glabrata&#xD;
&#xD;
       30. Candida guilliermondii&#xD;
&#xD;
       31. Candida haemulonis&#xD;
&#xD;
       32. Candida inconspicua&#xD;
&#xD;
       33. Candida kefyr&#xD;
&#xD;
       34. Candida krusei&#xD;
&#xD;
       35. Candida lambica&#xD;
&#xD;
       36. Candida lipolytica&#xD;
&#xD;
       37. Candida lusitaniae&#xD;
&#xD;
       38. Candida metapsilosis&#xD;
&#xD;
       39. Candida norvegensis&#xD;
&#xD;
       40. Candida orthopsilosis&#xD;
&#xD;
       41. Candida parapsilosis&#xD;
&#xD;
       42. Candida pararugosa&#xD;
&#xD;
       43. Candida pelliculosa&#xD;
&#xD;
       44. Candida tropicalis&#xD;
&#xD;
       45. Candida valida&#xD;
&#xD;
       46. Capnocytophaga ochracea&#xD;
&#xD;
       47. Capnocytophaga sputigena&#xD;
&#xD;
       48. Chryseobacterium gleum&#xD;
&#xD;
       49. Chryseobacterium indologenes&#xD;
&#xD;
       50. Clostridium difficile&#xD;
&#xD;
       51. Clostridium perfringens&#xD;
&#xD;
       52. Corynebacterium amycolatum&#xD;
&#xD;
       53. Corynebacterium bovis&#xD;
&#xD;
       54. Corynebacterium diphtheriae&#xD;
&#xD;
       55. Corynebacterium glucuronolyticum&#xD;
&#xD;
       56. Corynebacterium jeikeium&#xD;
&#xD;
       57. Corynebacterium kroppenstedtii&#xD;
&#xD;
       58. Corynebacterium macginleyi&#xD;
&#xD;
       59. Corynebacterium minutissimum&#xD;
&#xD;
       60. Corynebacterium propinquum&#xD;
&#xD;
       61. Corynebacterium pseudodiphtheriticum&#xD;
&#xD;
       62. Corynebacterium riegelii&#xD;
&#xD;
       63. Corynebacterium tuberculostearicum&#xD;
&#xD;
       64. Corynebacterium ulcerans&#xD;
&#xD;
       65. Corynebacterium urealyticum&#xD;
&#xD;
       66. Corynebacterium xerosis&#xD;
&#xD;
       67. Corynebacterium_aurimucosum group&#xD;
&#xD;
       68. Corynebacterium_striatum group&#xD;
&#xD;
       69. Cronobacter_sakazakii group&#xD;
&#xD;
       70. Cryptococcus gattii&#xD;
&#xD;
       71. Cryptococcus neoformans_var_grubii&#xD;
&#xD;
       72. Cryptococcus neoformans_var_neoformans&#xD;
&#xD;
       73. Cupriavidus_pauculus group&#xD;
&#xD;
       74. Delftia_acidovorans group&#xD;
&#xD;
       75. Dermacoccus nishinomiyaensis&#xD;
&#xD;
       76. Edwardsiella tarda&#xD;
&#xD;
       77. Elizabethkingia_meningoseptica group&#xD;
&#xD;
       78. Enterobacter amnigenus&#xD;
&#xD;
       79. Enterococcus casseliflavus&#xD;
&#xD;
       80. Enterococcus faecalis&#xD;
&#xD;
       81. Enterococcus faecium&#xD;
&#xD;
       82. Enterococcus gallinarum&#xD;
&#xD;
       83. Enterococcus hirae&#xD;
&#xD;
       84. Enterococcus_avium group&#xD;
&#xD;
       85. Finegoldia magna&#xD;
&#xD;
       86. Fusobacterium canifelinum&#xD;
&#xD;
       87. Fusobacterium necrophorum&#xD;
&#xD;
       88. Fusobacterium nucleatum&#xD;
&#xD;
       89. Gardnerella vaginalis&#xD;
&#xD;
       90. Gemella haemolysans&#xD;
&#xD;
       91. Gemella sanguinis&#xD;
&#xD;
       92. Geotrichum candidum&#xD;
&#xD;
       93. Geotrichum capitatum&#xD;
&#xD;
       94. Granulicatella adiacens&#xD;
&#xD;
       95. Haemophilus haemolyticus&#xD;
&#xD;
       96. Haemophilus influenzae&#xD;
&#xD;
       97. Haemophilus_parahaemolyticus group&#xD;
&#xD;
       98. Kingella kingae&#xD;
&#xD;
       99. Kloeckera apiculata&#xD;
&#xD;
      100. Kocuria kristinae&#xD;
&#xD;
      101. Kytococcus sedentarius&#xD;
&#xD;
      102. Lactococcus garvieae&#xD;
&#xD;
      103. Lactococcus lactis&#xD;
&#xD;
      104. Leuconostoc mesenteroides&#xD;
&#xD;
      105. Macrococcus caseolyticus&#xD;
&#xD;
      106. Micrococcus luteus&#xD;
&#xD;
      107. Moraxella_sg_Moraxella nonliquefaciens&#xD;
&#xD;
      108. Myroides odoratimimus&#xD;
&#xD;
      109. Myroides odoratus&#xD;
&#xD;
      110. Oligella ureolytica&#xD;
&#xD;
      111. Oligella urethralis&#xD;
&#xD;
      112. Parabacteroides distasonis&#xD;
&#xD;
      113. Pediococcus pentosaceus&#xD;
&#xD;
      114. Peptoniphilus_harei group&#xD;
&#xD;
      115. Peptostreptococcus anaerobius&#xD;
&#xD;
      116. Pichia ohmeri&#xD;
&#xD;
      117. Plesiomonas shigelloides&#xD;
&#xD;
      118. Porphyromonas gingivalis&#xD;
&#xD;
      119. Prevotella bivia&#xD;
&#xD;
      120. Prevotella buccae&#xD;
&#xD;
      121. Prevotella denticola&#xD;
&#xD;
      122. Prevotella intermedia&#xD;
&#xD;
      123. Prevotella melaninogenica&#xD;
&#xD;
      124. Propionibacterium acnes&#xD;
&#xD;
      125. Pseudomonas stutzeri&#xD;
&#xD;
      126. Rhizobium radiobacter&#xD;
&#xD;
      127. Rothia aeria&#xD;
&#xD;
      128. Rothia dentocariosa&#xD;
&#xD;
      129. Rothia mucilaginosa&#xD;
&#xD;
      130. Saccharomyces cerevisiae&#xD;
&#xD;
      131. Serratia plymuthica&#xD;
&#xD;
      132. Serratia rubidaea&#xD;
&#xD;
      133. Staphylococcus aureus&#xD;
&#xD;
      134. Staphylococcus auricularis&#xD;
&#xD;
      135. Staphylococcus capitis&#xD;
&#xD;
      136. Staphylococcus caprae&#xD;
&#xD;
      137. Staphylococcus carnosus&#xD;
&#xD;
      138. Staphylococcus cohnii&#xD;
&#xD;
      139. Staphylococcus epidermidis&#xD;
&#xD;
      140. Staphylococcus equorum&#xD;
&#xD;
      141. Staphylococcus felis&#xD;
&#xD;
      142. Staphylococcus haemolyticus&#xD;
&#xD;
      143. Staphylococcus hominis&#xD;
&#xD;
      144. Staphylococcus lugdunensis&#xD;
&#xD;
      145. Staphylococcus pasteuri&#xD;
&#xD;
      146. Staphylococcus pettenkoferi&#xD;
&#xD;
      147. Staphylococcus pseudintermedius&#xD;
&#xD;
      148. Staphylococcus saccharolyticus&#xD;
&#xD;
      149. Staphylococcus saprophyticus&#xD;
&#xD;
      150. Staphylococcus schleiferi&#xD;
&#xD;
      151. Staphylococcus simulans&#xD;
&#xD;
      152. Staphylococcus vitulinus&#xD;
&#xD;
      153. Staphylococcus warneri&#xD;
&#xD;
      154. Streptococcus agalactiae&#xD;
&#xD;
      155. Streptococcus anginosus&#xD;
&#xD;
      156. Streptococcus constellatus&#xD;
&#xD;
      157. Streptococcus dysgalactiae&#xD;
&#xD;
      158. Streptococcus gallolyticus&#xD;
&#xD;
      159. Streptococcus gordonii&#xD;
&#xD;
      160. Streptococcus intermedius&#xD;
&#xD;
      161. Streptococcus lutetiensis&#xD;
&#xD;
      162. Streptococcus mutans&#xD;
&#xD;
      163. Streptococcus pneumoniae&#xD;
&#xD;
      164. Streptococcus pyogenes&#xD;
&#xD;
      165. Streptococcus salivarius&#xD;
&#xD;
      166. Streptococcus_mitis_oralis group&#xD;
&#xD;
      167. Sutterella wadsworthensis&#xD;
&#xD;
      168. Trichosporon asahii&#xD;
&#xD;
      169. Vibrio parahaemolyticus&#xD;
&#xD;
      170. Vibrio vulnificus&#xD;
&#xD;
      sg = subgenus sp=species var = variety&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Substantial equivalence of MBT-CA with sequencing concerning determination of the respective bacteria and yeasts</measure>
    <time_frame>half a year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Infection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with infections from certain yeasts, Gram positive or certain Gram negative&#xD;
        bacteria (see Further Information / Target microorganisms of study)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        -Patients with infections from certain yeasts, Gram positive or Gram negative bacteria (see&#xD;
        Detailed Description)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -Patients without infections from the quoted microorganisms (see Detailed Description)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bruker Daltonik GmbH</name>
      <address>
        <city>Bremen</city>
        <zip>28359</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Kostrzewa, Ph:D.</last_name>
      <email>markus.kostrzewa@bruker.com</email>
    </contact>
    <contact_backup>
      <last_name>Jens Pfannkuche, Ph.D.</last_name>
      <email>jens.pfannkuche@bruker.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <study_first_submitted>March 25, 2014</study_first_submitted>
  <study_first_submitted_qc>March 26, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2014</study_first_posted>
  <last_update_submitted>February 5, 2015</last_update_submitted>
  <last_update_submitted_qc>February 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

